SEMAGLUTIDE WARNING: WHO Alerts Public to Dangerous Falsified Weight Loss Medications
Geneva, Switzerland – The World Health Organization (WHO) issued a warning on Thursday regarding the rise of falsified weight-loss medications, urging both the general public and healthcare professionals to remain vigilant. Specifically, the WHO raised concerns about counterfeit semaglutide drugs, commonly used for weight loss purposes. The agency highlighted three instances of fake Ozempic batches in Brazil, the U.K., and the U.S. that surfaced late last year. These counterfeits were not manufactured by Novo Nordisk, …